Loading clinical trials...
Loading clinical trials...
FINE-REAL Korea: A Non-interventional Study Providing Insights Into the Use of Finerenone in a Routine Clinical Setting in Korea
Conditions
Interventions
Kerendia (Finerenone, BAY94-8862)
Locations
1
South Korea
Many Locations
Multiple Locations, South Korea
Start Date
November 20, 2025
Primary Completion Date
September 30, 2027
Completion Date
January 28, 2028
Last Updated
April 17, 2026
NCT07547098
NCT06278207
NCT07493642
NCT07241390
NCT07051005
NCT05728216
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions